I have been asked to serve as a non-voting patient representative for the FDA Neurological Devices Panel which is meeting Friday March 31 to consider extenting the use of deep brain stimulation for Parkinson's Disease. The meeting is open to the public and will be at the DoubleTree Hotel, 1750 Rockville Pike, Rockville MD from 10 AM until 5:30 PM. Comments and advice are welcome. Perry Cohen